Laddar...
Aflibercept Traps Galectin-1, an Angiogenic Factor Associated with Diabetic Retinopathy
Vascular endothelial growth factor (VEGF)-A-driven angiogenesis contributes to various disorders including cancer and proliferative diabetic retinopathy (PDR). Among several VEGF-A blockers clinically used is aflibercept, a chimeric VEGFR1/VEGFR2-based decoy receptor fused to the Fc fragment of IgG1...
Sparad:
| I publikationen: | Sci Rep |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Nature Publishing Group
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4673700/ https://ncbi.nlm.nih.gov/pubmed/26648523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/srep17946 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|